Fiche centre
ATP Clinical Research
Costa Mesa — United States
Essais liés4clinical trials
VilleCosta Mesalocalisation
PaysUnited Stateslocalisation
SourcelocaleCSV/MySQL
Informations
centreSynchronisé depuis ClinicalTrials.gov — NCT06651567
Essais cliniques associés
4| Molécule | Indication / population | Phase | NCT | Titre | Statut |
|---|---|---|---|---|---|
| Piromelatine 20 mg | Alzheimer | Phase 2/3 | NCT05267535 | Piromelatine 20 mg in Participants With Mild Dementia Due to Alzheimer's Disease | TERMINATED |
| ACP-204 | Alzheimer | Phase 2/3 | NCT06159673 | ACP-204 in Adults With Alzheimer's Disease Psychosis | RECRUITING |
| ITI-1284 | Alzheimer | Phase 2 | NCT06651567 | A Study to Assess the Efficacy and Safety of ITI-1284 in the Treatment of Agitation Associated With Alzheimer's Dementia | RECRUITING |
| ACP-204 | Alzheimer | Phase 3 | NCT06194799 | ACP-204 in Adults With Alzheimer's Disease Psychosis Open Label Extension Study | ENROLLING_BY_INVITATION |